1 型和 2 型糖尿病的护理质量 - AMD 年报倡议的 2023 年更新。

IF 6.1 3区 医学 Q1 ENDOCRINOLOGY & METABOLISM
G. Russo , S. De Cosmo , P. Di Bartolo , G. Lucisano , V. Manicardi , A. Nicolucci , A. Rocca , M.C. Rossi , G. Di Cianni , R. Candido , AMD Annals Study Group
{"title":"1 型和 2 型糖尿病的护理质量 - AMD 年报倡议的 2023 年更新。","authors":"G. Russo ,&nbsp;S. De Cosmo ,&nbsp;P. Di Bartolo ,&nbsp;G. Lucisano ,&nbsp;V. Manicardi ,&nbsp;A. Nicolucci ,&nbsp;A. Rocca ,&nbsp;M.C. Rossi ,&nbsp;G. Di Cianni ,&nbsp;R. Candido ,&nbsp;AMD Annals Study Group","doi":"10.1016/j.diabres.2024.111743","DOIUrl":null,"url":null,"abstract":"<div><h3>Aims</h3><p>An initiative of continuous monitoring of the quality of diabetes care, promoted by the Association of Medical Diabetologists, is in place in Italy since 2006 (AMD Annals). The initiative was effective in improving quality of care indicators, assessed periodically through standardized measures. Here, we show the 2023 AMD Annals data on type 2 (T2D) and type 1 (T1D) diabetes.</p></div><div><h3>Methods</h3><p>A network of over 1/3 of diabetes centers in Italy periodically extracts anonymous data from electronic medical records, using a standardized software. Process, treatment and outcome indicators, and a validated score of overall care, the Q-score, were evaluated.</p></div><div><h3>Results</h3><p>296 centers provided data on 573,164 T2D (mean age 69.7 ± 11.2 years) and 42,611 T1D subjects (mean age 48.6 ± 16.9 years). A HbA1c value ≤ 7.0 % was documented in 56.3 % of patients with T2D and 35.9 % of those with T1D. Only 6.6 % of T2D patients and 3.5 % of those with T1D reached the composite outcome of HbA1c ≤ 7.0 % + LDL-C &lt; 70 mg/dl + BP &lt; 130/80 mmHg. Notably, only 2.8 % and 3.2 % of T2D and T1D patients, respectively, showed a Q score &lt; 15, which correlates with an 80 % higher risk of incident CVD events compared to scores &gt; 25.</p></div><div><h3>Conclusions</h3><p>We documented an overall good quality of care in both T1D and T2D subjects. However, the failure to achieve the targets of the main risk factors, especially if combined, in a still too large proportion of patients testify the difficulty to apply the more and more stringent indications recommended by guidelines in the everyday clinical practice.</p></div>","PeriodicalId":11249,"journal":{"name":"Diabetes research and clinical practice","volume":null,"pages":null},"PeriodicalIF":6.1000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The quality of care in type 1 and type 2 diabetes – A 2023 update of the AMD Annals initiative\",\"authors\":\"G. Russo ,&nbsp;S. De Cosmo ,&nbsp;P. Di Bartolo ,&nbsp;G. Lucisano ,&nbsp;V. Manicardi ,&nbsp;A. Nicolucci ,&nbsp;A. Rocca ,&nbsp;M.C. Rossi ,&nbsp;G. Di Cianni ,&nbsp;R. Candido ,&nbsp;AMD Annals Study Group\",\"doi\":\"10.1016/j.diabres.2024.111743\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Aims</h3><p>An initiative of continuous monitoring of the quality of diabetes care, promoted by the Association of Medical Diabetologists, is in place in Italy since 2006 (AMD Annals). The initiative was effective in improving quality of care indicators, assessed periodically through standardized measures. Here, we show the 2023 AMD Annals data on type 2 (T2D) and type 1 (T1D) diabetes.</p></div><div><h3>Methods</h3><p>A network of over 1/3 of diabetes centers in Italy periodically extracts anonymous data from electronic medical records, using a standardized software. Process, treatment and outcome indicators, and a validated score of overall care, the Q-score, were evaluated.</p></div><div><h3>Results</h3><p>296 centers provided data on 573,164 T2D (mean age 69.7 ± 11.2 years) and 42,611 T1D subjects (mean age 48.6 ± 16.9 years). A HbA1c value ≤ 7.0 % was documented in 56.3 % of patients with T2D and 35.9 % of those with T1D. Only 6.6 % of T2D patients and 3.5 % of those with T1D reached the composite outcome of HbA1c ≤ 7.0 % + LDL-C &lt; 70 mg/dl + BP &lt; 130/80 mmHg. Notably, only 2.8 % and 3.2 % of T2D and T1D patients, respectively, showed a Q score &lt; 15, which correlates with an 80 % higher risk of incident CVD events compared to scores &gt; 25.</p></div><div><h3>Conclusions</h3><p>We documented an overall good quality of care in both T1D and T2D subjects. However, the failure to achieve the targets of the main risk factors, especially if combined, in a still too large proportion of patients testify the difficulty to apply the more and more stringent indications recommended by guidelines in the everyday clinical practice.</p></div>\",\"PeriodicalId\":11249,\"journal\":{\"name\":\"Diabetes research and clinical practice\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":6.1000,\"publicationDate\":\"2024-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diabetes research and clinical practice\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0168822724006533\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes research and clinical practice","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0168822724006533","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

摘要

目的:自 2006 年起,意大利开始实施一项由糖尿病内科医生协会推动的糖尿病护理质量持续监测计划(AMD Annals)。该倡议通过标准化措施定期评估,有效提高了护理质量指标。在此,我们展示了 2023 年 AMD 年鉴中有关 2 型(T2D)和 1 型(T1D)糖尿病的数据:方法:由意大利超过 1/3 的糖尿病中心组成的网络使用标准化软件定期从电子病历中提取匿名数据。结果:296 个中心提供了 573 164 名 T2D 患者(平均年龄为 69.7±11.2 岁)和 42 611 名 T1D 患者(平均年龄为 48.6±16.9 岁)的数据。56.3%的 T2D 患者和 35.9% 的 T1D 患者的 HbA1c 值≤7.0%。只有 6.6% 的 T2D 患者和 3.5% 的 T1D 患者达到了 HbA1c≤7.0% + LDL-C 25 的综合结果:根据我们的记录,T1D 和 T2D 患者的护理质量总体良好。然而,仍有很大一部分患者未能达到主要危险因素的目标,尤其是在合并危险因素的情况下,这证明在日常临床实践中很难应用指南建议的越来越严格的适应症。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The quality of care in type 1 and type 2 diabetes – A 2023 update of the AMD Annals initiative

Aims

An initiative of continuous monitoring of the quality of diabetes care, promoted by the Association of Medical Diabetologists, is in place in Italy since 2006 (AMD Annals). The initiative was effective in improving quality of care indicators, assessed periodically through standardized measures. Here, we show the 2023 AMD Annals data on type 2 (T2D) and type 1 (T1D) diabetes.

Methods

A network of over 1/3 of diabetes centers in Italy periodically extracts anonymous data from electronic medical records, using a standardized software. Process, treatment and outcome indicators, and a validated score of overall care, the Q-score, were evaluated.

Results

296 centers provided data on 573,164 T2D (mean age 69.7 ± 11.2 years) and 42,611 T1D subjects (mean age 48.6 ± 16.9 years). A HbA1c value ≤ 7.0 % was documented in 56.3 % of patients with T2D and 35.9 % of those with T1D. Only 6.6 % of T2D patients and 3.5 % of those with T1D reached the composite outcome of HbA1c ≤ 7.0 % + LDL-C < 70 mg/dl + BP < 130/80 mmHg. Notably, only 2.8 % and 3.2 % of T2D and T1D patients, respectively, showed a Q score < 15, which correlates with an 80 % higher risk of incident CVD events compared to scores > 25.

Conclusions

We documented an overall good quality of care in both T1D and T2D subjects. However, the failure to achieve the targets of the main risk factors, especially if combined, in a still too large proportion of patients testify the difficulty to apply the more and more stringent indications recommended by guidelines in the everyday clinical practice.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Diabetes research and clinical practice
Diabetes research and clinical practice 医学-内分泌学与代谢
CiteScore
10.30
自引率
3.90%
发文量
862
审稿时长
32 days
期刊介绍: Diabetes Research and Clinical Practice is an international journal for health-care providers and clinically oriented researchers that publishes high-quality original research articles and expert reviews in diabetes and related areas. The role of the journal is to provide a venue for dissemination of knowledge and discussion of topics related to diabetes clinical research and patient care. Topics of focus include translational science, genetics, immunology, nutrition, psychosocial research, epidemiology, prevention, socio-economic research, complications, new treatments, technologies and therapy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信